Molecular determinants of rotavirus virulence: Localization of a potential virulence site in a murine rotavirus VP4
Autor: | K. F. Ready, M.K. Ijaz, L. A. Babiuk, T. Alkarmi, M. I. Sabara, F.K. Dar, P.J. Frenchick |
---|---|
Rok vydání: | 1994 |
Předmět: |
Rotavirus
viruses Immunology Reoviridae Virulence modèles animaux medicine.disease_cause Microbiology Article Virus Mice Capsid In vivo Rotaviruses Chlorocebus aethiops medicine Animals Immunology and Allergy pathogénèse Gene General Veterinary biology pathogenesis virus modifiés virulence determinant General Medicine biology.organism_classification Virology animal models In vitro Infectious Diseases reassortants déterminant de la virulence Cattle |
Zdroj: | Comparative Immunology, Microbiology and Infectious Diseases |
ISSN: | 0147-9571 |
Popis: | The molecular basis of pathogenesis in vivo for a virulent mouse rotavirus (MRV) and a less virulent bovine rotavirus (BRV) were compared under in vitro and in vivo conditions. Obvious differences in the mobility of several genomic RNA segments were observed in one-dimensional gels. Under in vitro conditions, partial proteolytic peptide mapping identified differences between the two outer capsid proteins of these virus and no difference in inner capsid protein was observed. Since it has been observed by us and others that the gene coding for VP4 protein plays a significant role in determining virulence, the variability observed in the present study between the 84 k proteins (VP4) provided a basis for further investigations in order to locate a potential virulence determinant. A comparison of the carboxypeptidase digests of the MRV- and BRV-VP4 revealed an area of variability between amino acids 307 and 407, which may represent a site of virulence determinant. Under in vivo conditions the virulence of both parenteral BRV and MRV isolates and their corresponding reassortants (with replaced gene 4) were studied in murine and bovine hosts. Like their parents, BRV and MRV isolates, reassortants obtained by replacement of gene 4 in BRV with MRV gene 4 indicated that the dose of the virus isolate used and the clinical outcome in vivo was determined by gene segment 4. The implications of these findings to elucidate the molecular basis of pathogenesis of rotaviruses are discussed. |
Databáze: | OpenAIRE |
Externí odkaz: |